SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-287901
Filing Date
2021-09-30
Accepted
2021-09-30 15:38:26
Documents
57
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q d193824d10q.htm   iXBRL 10-Q 774519
2 EX-31.1 d193824dex311.htm EX-31.1 10540
3 EX-31.2 d193824dex312.htm EX-31.2 10620
4 EX-32 d193824dex32.htm EX-32 5301
  Complete submission text file 0001193125-21-287901.txt   4294464

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA neog-20210831.xsd EX-101.SCH 30205
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20210831_cal.xml EX-101.CAL 32887
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20210831_def.xml EX-101.DEF 245860
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20210831_lab.xml EX-101.LAB 307279
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20210831_pre.xml EX-101.PRE 278713
10 EXTRACTED XBRL INSTANCE DOCUMENT d193824d10q_htm.xml XML 600323
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 211295011
SIC: 2835 In Vitro & In Vivo Diagnostic Substances